Sarcopenia and type 2 diabetes mellitus

A bidirectional relationship

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)

Abstract

The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter-and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.

Original languageEnglish
Pages (from-to)1057-1072
Number of pages16
JournalDiabetes, Metabolic Syndrome and Obesity: targets and therapy
Volume12
DOIs
Publication statusPublished - 8 Jul 2019

Keywords

  • Metabolic health
  • Muscle health
  • Obesity
  • Sarcopenia
  • Type 2 diabetes mellitus

Cite this

@article{e3e0c600ccc246d0842305b104c650c4,
title = "Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship",
abstract = "The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter-and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.",
keywords = "Metabolic health, Muscle health, Obesity, Sarcopenia, Type 2 diabetes mellitus",
author = "Jakub Mesinovic and Ayse Zengin and {Vozarova de Courten}, Barbora and Peter Ebeling and David Scott",
year = "2019",
month = "7",
day = "8",
doi = "10.2147/DMSO.S186600",
language = "English",
volume = "12",
pages = "1057--1072",
journal = "Diabetes, Metabolic Syndrome and Obesity: targets and therapy",
issn = "1178-7007",
publisher = "Dove Medical Press Ltd.",

}

Sarcopenia and type 2 diabetes mellitus : A bidirectional relationship. / Mesinovic, Jakub; Zengin, Ayse; Vozarova de Courten, Barbora; Ebeling, Peter; Scott, David.

In: Diabetes, Metabolic Syndrome and Obesity: targets and therapy, Vol. 12, 08.07.2019, p. 1057-1072.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Sarcopenia and type 2 diabetes mellitus

T2 - A bidirectional relationship

AU - Mesinovic, Jakub

AU - Zengin, Ayse

AU - Vozarova de Courten, Barbora

AU - Ebeling, Peter

AU - Scott, David

PY - 2019/7/8

Y1 - 2019/7/8

N2 - The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter-and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.

AB - The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter-and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.

KW - Metabolic health

KW - Muscle health

KW - Obesity

KW - Sarcopenia

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85071273662&partnerID=8YFLogxK

U2 - 10.2147/DMSO.S186600

DO - 10.2147/DMSO.S186600

M3 - Review Article

VL - 12

SP - 1057

EP - 1072

JO - Diabetes, Metabolic Syndrome and Obesity: targets and therapy

JF - Diabetes, Metabolic Syndrome and Obesity: targets and therapy

SN - 1178-7007

ER -